SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C243 - Assessment of Rapidly Progressive Dementias II: Autoimmune Encephalopathies and Infections Presenting as Rapidly Progressive Dementia

Event Time: Friday April 28, 2017 3:30 pm to 5:30 pm
Topic(s): Aging, Dementia, Cognitive, and Behavioral Neurology
Director(s): Michael Geschwind MD, PhD
Description: Rapidly progressive dementia (RPD) can be challenging to diagnose. The differential diagnosis is broad and includes many potentially reversible conditions. As many RPD are treatable if treated early, quick diagnosis is important. Through presentation of common and challenging cases, faculty will review the differential diagnosis of RPD, the approach, and management strategies. This session will focus on infectious and autoimmune (mostly antibody-mediated) causes of RPD. This program complements C236: Assessment of Rapidly Progressive Dementias I: Overview, Prion Diseases and Neurodegenerative Rapidly Progressive Dementias, but covers independent topics.
Completion Message: Participants should be familiar with the differential diagnosis of infectious and non-prion neurodegenerative disease causes of RPD. They should understand the clinical presentation and be able to evaluate for the more common causes of RPD.
CME Credits: 2
Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism, Systems-Based Practice

Program Speakers - Tentative

Start/End Time Title Faculty
3:30 PM - 3:35 PM Introduction Michael Geschwind MD, PhD 
3:35 PM - 4:25 PM Infectious Causes of Rapidly Progressive Dementia Allen Aksamit MD, FAAN 
4:25 PM - 5:15 PM Autoimmune and Antibody-mediated Causes of Rapidly Progressive Dementia Jeffrey Gelfand MD, MAS, FAAN 
5:15 PM - 5:30 PM Questions and Answers Faculty 

Disclosures

Speaker Disclosure
Allen J. Aksamit, Jr., MD, FAAN Dr. Aksamit has nothing to disclose.

Jeffrey Marc Gelfand, MD, MAS, FAAN Dr. Gelfand has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with . Dr. Gelfand has received research support from Genentech and MedDay. He has also received personal compensation for medical legal consulting..

Michael D. Geschwind, MD, PhD Dr. Geschwind has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Quest Inc., Teva Pharmaceuticals, LCN Consulting, Biohaven Pharmaceuticals, Boccardo Law Firm, Kendell Brill Kelly LLC, Franciscan Physician's Network, Advance Medical Inc, Best Doctors, Gerson Lehrman Group, Oakstone Publishing,. Dr. Geschwind has received research support from Quest Diagnostics.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C1 Mild Cognitive Impairment: Implications for Clinicians Ronald Petersen PhD, MD, FAAN
9:30 AM-11:30 AM
C13 Neuroimaging Biomarkers Across the Dementia Spectrum Liana Apostolova MD, FAAN
C10 More than Medicine: How to Access Home Care, Support Caregivers, and Discuss Complex Situations in Advanced Neurologic Disease Farrah Daly MD, MBA
1:30 PM-3:30 PM
C19 The Neurology of Social Behavior Bradford Dickerson MD

Sunday April 22, 2018

7:00 AM-9:00 AM
C32 Clinicopathological Correlation Session in Dementia David Irwin MD

Monday April 23, 2018

7:00 AM-9:00 AM
C66 Cognitive Impairment due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment David Knopman MD, FAAN
1:00 PM-3:00 PM
C77 Present and Future Biomarkers in Dementia: A Case-based Approach Jonathan Graff-Radford MD
3:30 PM-5:30 PM
C91 Chronic Traumatic Encephalopathy: Update Andrew Budson MD

Tuesday April 24, 2018

7:00 AM-9:00 AM
C96 Vascular Cognitive Impairment and Dementia: Current Status and Future Larry Goldstein MD, FAAN, FAHA
1:00 PM-3:00 PM
N3 Neuroscience in the Clinic: Challenges in Genetic Diagnosis in Neurology Guy Rouleau MD, PhD,
Massimo Pandolfo MD, FAAN
C105 Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Daniel Kaufer MD, FAAN
C108 Neurologic Complications in Adults with Down Syndrome Andrea Gropman MD
3:30 PM-5:30 PM
C129 Disorders of Motor Programming: The Apraxias and Action-Intentional Disorders Chalk Talk Kenneth Heilman MD, FAAN

Wednesday April 25, 2018

7:00 AM-9:00 AM
C134 Neurocognitive Assessment for Neurologists Mario Mendez MD, PhD, FAAN
C132 Higher Cortical Visual Disorders: Case-based Review Sashank Prasad MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C144 Severe TBI: From ICU to Rehabilitation Susanne Muehlschlegel MD, MPH
C145 Non-Alzheimer's Dementia I: Frontotemporal Dementias Gil Rabinovici MD
3:30 PM-5:30 PM
C160 Non-Alzheimer's Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias Gil Rabinovici MD

Friday April 27, 2018

7:00 AM-9:00 AM
C218 The Early-Onset Dementias Mario Mendez MD, PhD, FAAN
1:00 PM-3:00 PM
C226 Behavioral Neurology: A Case-based Approach A. Barrett MD, FAAN
3:30 PM-5:30 PM
C237 Memory Disorders: A Case-based Approach David Wolk MD

MEMBER LOG IN

Forgot Password?